Kamada (KMDA) Gains from Investment Securities (2016 - 2017)
Kamada (KMDA) posted quarterly Gains from Investment Securities of $649000.0 for Q3 2017, down 86.82% year-on-year from $4.9 million in Q3 2016, and down 86.82% on a QoQ basis from $4.9 million in Q3 2016.
Kamada (KMDA) Gains from Investment Securities (2016 - 2017) Analysis & Trends
Kamada (KMDA) has reported Gains from Investment Securities for 2 consecutive years, with $649000.0 the latest figure, recorded in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Kamada | 399.49 Mn | 326.34 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 649,000.00 |
| Sep 30, 2017 | 649,000.00 |
| Sep 30, 2016 | 4.93 Mn |
| Sep 30, 2016 | 4.93 Mn |